A Mobile App to Improve 24-Hour Movement Guideline Adherence in Preschoolers
Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Oct 30, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of a mobile app to help preschool-aged children (ages 3 to 4) follow the 24-Hour Movement Guidelines, which include recommendations for physical activity, screen time, and sleep. The study aims to find out if using the app can help more children meet all three guidelines and whether parents find it easy to use. To participate, children must currently meet 0 or 1 of these guidelines, and parents need to be comfortable using a smartphone and visiting the study location.
Families involved in the trial will track their child's activity and sleep using a small device called an accelerometer. Parents will receive weekly lessons and goals through the app to encourage healthy habits in their children. They will also fill out questionnaires about their child's behaviors and development at the beginning of the study and again after 6 and 12 weeks. Children will take part in tests to assess their motor skills, while parents will provide feedback on how their child is doing. This study aims to support families in helping their children develop healthier lifestyles.
Gender
ALL
Eligibility criteria
- Inclusion (Child):
- • Ages 3-4 years.
- • Parent report that they meet 0 or 1 recommendation for physical activity, sleep, and screen-time as defined by the 24-hour movement guidelines. The physical activity recommendation is defined as greater than or equal to 3 hours/day of total physical activity, including 1 hour of moderate-to-vigorous physical activity. The sleep recommendation is defined as 10-13 hours/day. The sedentary behavior recommendation is defined as less than or equal to 1 hour/day of sedentary screen-time.
- Inclusion (Parents):
- • Parents must agree to use their mobile phone for the duration of the study (\~12 weeks) and download the mobile app onto their phone.
- • The parent/caregiver is fluent in English to participate in testing the mobile app.
- • The parent/caregiver must be willing to travel to KUMC to complete study visits.
- Exclusion (child):
- • Mobility limitations as reported by the parent.
- • Meeting two or more recommendations for physical activity, sleep, and screen-time.
- • Sibling or household member is participating or participated in the study.
About University Of Kansas Medical Center
The University of Kansas Medical Center (KUMC) is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent clinical trial sponsor, KUMC leverages its extensive expertise in diverse medical fields to conduct rigorous clinical research aimed at improving patient outcomes and developing new treatment modalities. With a commitment to ethical standards and patient safety, KUMC collaborates with multidisciplinary teams to facilitate groundbreaking studies that address significant health challenges, ultimately contributing to the advancement of medical knowledge and the enhancement of community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Kansas, United States
Patients applied
Trial Officials
Dr. Chelsea L Kracht, PhD
Principal Investigator
University of Kansas Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported